Sergey D. Egranov

1.0k total citations
6 papers, 288 citations indexed

About

Sergey D. Egranov is a scholar working on Molecular Biology, Cancer Research and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Sergey D. Egranov has authored 6 papers receiving a total of 288 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Molecular Biology, 5 papers in Cancer Research and 1 paper in Pulmonary and Respiratory Medicine. Recurrent topics in Sergey D. Egranov's work include Cancer-related molecular mechanisms research (5 papers), RNA Research and Splicing (4 papers) and RNA modifications and cancer (3 papers). Sergey D. Egranov is often cited by papers focused on Cancer-related molecular mechanisms research (5 papers), RNA Research and Splicing (4 papers) and RNA modifications and cancer (3 papers). Sergey D. Egranov collaborates with scholars based in United States, China and Taiwan. Sergey D. Egranov's co-authors include Chunru Lin, Liuqing Yang, Yajuan Li, Qingsong Hu, Mien‐Chie Hung, David H. Hawke, Tina K. Nguyen, Ke Liang, Leng Han and Chunlai Li and has published in prestigious journals such as Journal of Clinical Investigation, Pharmacology & Therapeutics and Cell Research.

In The Last Decade

Sergey D. Egranov

6 papers receiving 284 citations

Peers

Sergey D. Egranov

MB

CR

NEPHR

PRM

EPIDE

Kaiming Ren China

Zhen Dong China

Xiaowei Qin China

Yujiao Sun China

Linsey J. F. Peters Netherlands

Shuangshuang Pu China

Fanwu Kong China

Ling Xie China

Jiao Wan China

Kaiming Ren China

Sergey D. Egranov

216 ×1.0

MB

181 ×1.0

CR

24 ×0.6

NEPHR

32 ×1.3

PRM

14 ×0.6

EPIDE

Citations per year, relative to Sergey D. Egranov Sergey D. Egranov (= 1×) peers Kaiming Ren

Countries citing papers authored by Sergey D. Egranov

Since Specialization

Citations

This map shows the geographic impact of Sergey D. Egranov's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sergey D. Egranov with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sergey D. Egranov more than expected).

Fields of papers citing papers by Sergey D. Egranov

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sergey D. Egranov. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sergey D. Egranov. The network helps show where Sergey D. Egranov may publish in the future.

Co-authorship network of co-authors of Sergey D. Egranov

This figure shows the co-authorship network connecting the top 25 collaborators of Sergey D. Egranov. A scholar is included among the top collaborators of Sergey D. Egranov based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sergey D. Egranov. Sergey D. Egranov is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

6 of 6 papers shown

1.

Li, Yajuan, Yaohua Zhang, Qingsong Hu, et al.. (2021). Functional significance of gain-of-function H19 lncRNA in skeletal muscle differentiation and anti-obesity effects. Genome Medicine. 13(1). 137–137. 17 indexed citations

2.

Hu, Qingsong, Sergey D. Egranov, Chunru Lin, & Liuqing Yang. (2020). Long noncoding RNA loss in immune suppression in cancer. Pharmacology & Therapeutics. 213. 107591–107591. 43 indexed citations

3.

Egranov, Sergey D., Qingsong Hu, Chunru Lin, & Liuqing Yang. (2020). LncRNAs as tumor cell intrinsic factors that affect cancer immunotherapy. RNA Biology. 17(11). 1625–1627. 13 indexed citations

4.

Hu, Qingsong, Chunlai Li, Shouyu Wang, et al.. (2019). LncRNAs-directed PTEN enzymatic switch governs epithelial–mesenchymal transition. Cell Research. 29(4). 286–304. 39 indexed citations

5.

Li, Yajuan, Qingsong Hu, Chunlai Li, et al.. (2019). PTEN-induced partial epithelial-mesenchymal transition drives diabetic kidney disease. Journal of Clinical Investigation. 129(3). 1129–1151. 91 indexed citations

6.

Li, Yajuan, Sergey D. Egranov, Liuqing Yang, & Chunru Lin. (2018). Molecular mechanisms of long noncoding RNAs‐mediated cancer metastasis. Genes Chromosomes and Cancer. 58(4). 200–207. 85 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact